Page 94 - Sohini Das

Covid-19: Dr Reddy's to distribute Russian vaccine in India. What we know

While Dr Reddy's Labs is preparing for clinical trials of Sputnik V, major manufacturers in the country are sceptical about the drug

Covid-19: Mass production of Sputnik V likely to take several months

Vaccine makers here feel the Sputnik is still a work in progress and needs time to develop

Russian vaccine on its way to India, pact signed with Dr Reddy's for trials

Talks are also on with five major Indian manufacturers here to produce the vaccine for India and the world

Festival spook: Covid-19 cases surge in Mumbai post Ganpati celebrations

Upcoming festival season is likely to push up Covid-19 numbers across the country

Spike in Covid-19 cases bares gaps in Delhi, Mumbai critical care infra

Industry says govt makeshift facilities lie vacant as patients scramble for private hospital beds

Serum Institute of India gets nod to resume Covid-19 vaccine trial

The resumption of trails was allowed after the vaccine maker submitted recommendations of the Data Safety Monitoring Board (DSMB), the UK, and DSMB, India

Aurobindo gears up for multiple Covid-19 vaccines, ties up with CSIR

Developing own candidate; to develop and make CSIR vaccine candiates

NPPA extends price cap on knee implants by a year to September 2021

A few weeks back, the pricing regulator had extended the price cap by a month after the earlier order validity ended in August

Paracetamol curbs amid Covid-19 pandemic dent sales during monsoon

Sales of paracetamol are typically high during monsoon when cold and flu ailments are common

AstraZeneca resumes clinical trials in UK after green signal

Meanwhile, DCGI asks Serum Institute to submit DSMB UK and India data to resume trials, after asking it to stop recruiting volunteers on Friday

Bharat Biotech's Covaxin succeeds in challenge trials on Rhesus monkeys

The results showed protective efficacacy, increasing Sars-CoV-2 specific IgG and neutralising antibodies reducing the replication of the virus in the nasal cavity, throat and lung tissues of monkey

Kochi firm gets nod to test India's first novel molecule for Covid-19

PNB Vesper's drug developed from 12 years of research for small-cell lung cancer (for which it is under trial) has shown positive response in Covid-19, the firm claims

Innovative therapy for coronavirus is required as much as a vaccine

Pharma giants have already started work on different formulations and combination therapies of their existing molecules

Unlock 4.0: User industries turn to innovations as economy opens up further

A gamechanger for offices and factories in the country, the Shycocan, which can clear an area of 1000 square feet from coronaviruses, was discovered by accident

Diagnostic labs pin hopes on Covid-19 test bouquets to revive revenues

Non-Covid revenues are back to 80% of Jan levels. Some expect demand to be 1.2 times pre-Covid level by Diwali

Remdesivir prices may rise after Gilead gets full authorisation from USFDA

In August, Gilead filed an application with the US Food and Drug Administration (USFDA) seeking full approval for remdesivir (Veklury)

Towards a new India: New e-health database rolls out via pilot projects

Modi's Independence Day speech focused on areas such as health and infra for a self-reliant New India. The first of a three-part series looks at the implications of the proposed Digital Health Mission

Health Ministry's guide for Covid-19 treatment drops itolizumab drug

FAQs for clinical management prepared by AIIMS and MoHFW says evidence for Favipiravir is weak

Covid-19 prescription: Pharma players shift their focus over the counter

The pandemic pushes pharma companies to look at drugs that held promise in transitioning to over the counter segment

Experts suggest policy changes to boost coronavirus research & development

Funding Covid-related research now included in CSR spends